News

DNA changes consistent with life-threatening pregnancy complications have been found in the placentas of pregnant women infected by COVID-19, according to University of Queensland researchers.

Two leading University of Queensland researchers have joined forces to begin developing an mRNA vaccine for children with brain cancer.

Two researchers from the Faculty of Medicine have been selected by Cure Cancer to receive funding in 2024.

UQ Faculty of Medicine researchers have received millions of dollars in funding from the National Health and Medical Research Council (NHMRC) to address a range of health challenges.

Researchers from The University of Queensland’s Frazer Institute have received $350,000 from the Translational Research Institute Australia (TRI) to accelerate medical research ‘from bench to bedside’.

Dr Clare Mahon from the University of Queensland’s Dermatology Research Centre has won the Community Award at the UQ Ventures LeadHers Awards.

Researchers from The University of Queensland and The Australian National University (ANU) have found that a protein which protects the body from fungal infections is also responsible for making certain diseases like irritable bowel disease (IBS), type 1 diabetes and eczema more severe.

UQ researcher, Dr Emma-Anne Karlsen, has been recognised at the prestigious global event, Falling Walls Lab, in Berlin. The PhD student placed third out of 100 participants from 64 countries in the Science Breakthrough of the Year category, receiving praise for her research on repurposing a low-cost and pre-existing drug to help expensive anti-cancer treatments work better and to fight tumours more effectively.

Researchers from UQ and The Alfred hospital in Melbourne have identified gene variants which may contribute to people being at higher risk for nodular melanoma.

University of Queensland researchers have identified a novel drug target with the potential to overcome drug resistance and prevent tumour regrowth in cancer patients.

Dr Emma-Anne Karlsen is completing her General Surgery training at the Mater Hospital Brisbane while studying her PhD with The University of Queensland Frazer Institute Simpson Lab.

University of Queensland researchers have supported a study to improve the performance of an artificial intelligence (AI) model in skin cancer diagnosis and management.

Frazer Institute’s Dr Timothy Wells and his research team are finalists in the category of Australian Infectious Diseases Research Centre Eureka Prize for Infectious Diseases Research, which is awarded for outstanding infectious diseases research that benefits, or has the potential to benefit, human health.

University of Queensland research fellow with the Frazer Institute, Dr Arutha Kulasinghe, has been awarded Cure Cancer’s prestigious Researcher of the Year title.

Topical corticosteroids, also referred to as corticosteroids or cortisone, are the go-to treatment for many skin disorders including eczema, dermatitis and psoriasis. They can be found in various forms such as creams, ointments, and solutions.

Co-creator of the cervical cancer vaccine, Gardasil, Emeritus Professor Frazer has been announced as Queensland’s Biomedical Advisor.

University of Queensland Professor H. Peter Soyer has been awarded the 2023 Silver Medal by the Australasian College of Dermatologists (ACD) – its highest award.

University of Queensland researchers have established Australia’s first Familial Melanoma Clinic at the Princess Alexandra Hospital to improve health outcomes for families with a history of melanoma.

A University of Queensland study has found skin with few visible freckles or blemishes may still carry sun-damaged DNA mutations that can trigger cancer.

Doctors may soon be able to better monitor brain cancer in children and potentially predict the tumour progress and therapy response, thanks to University of Queensland-led research, funded by the Children’s Hospital Foundation.